I'm LongbridgeAI, I can summarize articles.In Thursday's pre-market session, several healthcare stocks saw significant movement. Gainers included Adicet Bio (+22.9%), Bio-Techne (+19.83%), and TELA Bio (+14.65%). Conversely, ARS Pharmaceuticals dropped 28.9%, Passage Bio fell 22.11%, and Valion Bio decreased 14.63%. The report highlights specific percentage changes and market capitalizations for these active securities.
Gainers
- Adicet Bio (NASDAQ:ACET) stock moved upwards by 22.9% to $10.14 during Thursday's pre-market session. The market value of their outstanding shares is at $77.1 million.
- Bio-Techne (NASDAQ:TECH) stock moved upwards by 19.83% to $70.55. The market value of their outstanding shares is at $9.1 billion.
- TELA Bio (NASDAQ:TELA) stock increased by 14.65% to $0.86. The market value of their outstanding shares is at $33.5 million.
- Lakewood-Amedex (NASDAQ:LABT) shares rose 11.55% to $4.15. The company's market cap stands at $6.5 million.
- Incannex Healthcare (NASDAQ:IXHL) shares increased by 10.15% to $3.58. The market value of their outstanding shares is at $38.8 million.
- Scilex Holding (NASDAQ:SCLX) shares rose 10.05% to $7.55. The market value of their outstanding shares is at $48.2 million.
Losers
- ARS Pharmaceuticals (NASDAQ:SPRY) stock declined by 28.9% to $7.49 during Thursday's pre-market session. The company's market cap stands at $1.0 billion.
- Passage Bio (NASDAQ:PASG) shares declined by 22.11% to $4.58. The market value of their outstanding shares is at $18.8 million.
- Valion Bio (NASDAQ:VBIO) stock decreased by 14.63% to $0.46. The market value of their outstanding shares is at $1.7 million.
- Profusa (NASDAQ:PFSA) stock decreased by 14.16% to $0.11.
- Pulsenmore (NASDAQ:PLSM) shares fell 12.14% to $5.79. The market value of their outstanding shares is at $42.8 million.
- Azitra (AMEX:AZTR) shares decreased by 10.86% to $0.19. The market value of their outstanding shares is at $3.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to unlock921characters for free
Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.